Navigation Links
The American Society of Interventional Pain Physicians Announces Guidelines for Responsible Prescribing of Pain-Killers for Chronic Non-Cancer Pain
Date:8/1/2012

NEW YORK, Aug. 1, 2012 /PRNewswire/ -- The American Society of Interventional Pain Physicians (ASIPP), a national medical society of over 4,000 members, has released its "Guidelines for Responsible Opioid Prescribing in Chronic Non-Cancer Pain." A multidisciplinary panel of 55 medical experts drafted this comprehensive two-part guideline to improve patient care, curtail the abuse of opioids without jeopardizing non-cancer pain management treatments, and improve understanding among law enforcement agencies, lawmakers, insurance providers and regulatory agencies.

Dr.  Laxmaiah Manchikanti, founder and CEO of ASIPP stated, "Opioid abuse has increased at an alarming rate since the 1990's and physicians must be proactive and take all necessary steps to ensure that their patients are properly assessed, diagnosed and monitored while receiving opioid treatment. This report provides clear and concise guidelines to improve patient access and avoid diversion and abuse."

In 2005, ASIPP published the first guidelines for prescribing opioids and the 2012 revised version was published in the July issue of Pain Physician, a high impact (IF 10.7) peer reviewed journal. Part 1 of the 2012 Guidelines reviews various aspects of opioid use, misuse, abuse, overuse and resulting fatalities.  It presents statements of best practice based on a thorough evaluation of evidence from published studies on treatments outcomes. Part 2 provides recommendations for initiation and maintaining of appropriate chronic opioid therapy for 90 days or longer.

The 2012 guidelines illustrate a 10-step process with comprehensive assessment and documentation process, establishing medical necessity and treatment goals, recommendations for responsible opioid therapy with dose limitations, and necessity for a comprehensive and robust patient agreement.

It also discusses adherence monitoring, evaluation of side effects and discontinuation or maintenance of opioid therapy on a long-term basis additionally the report covers the means and ways to initiate opioid therapy, specific guidelines for methadone use, and reduction in prescription drug dose.

About the American Society of Interventional Pain Physicians
ASIPP promotes the development and practice of safe, high-quality, cost-effective interventional pain management techniques for the diagnosis and treatment of pain and related disorders, and to ensure patient access to these interventions.   For more information, visit www.asipp.org or call 270.554.9412. Ext. 215.


'/>"/>
SOURCE American Society of Interventional Pain Physicians
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. American Academy of Family Physicians Foundation Launches Cities for Life
2. Interim results of VITOBA™ (VImpaT® added to One Baseline AED) Study Presented at the 64th Annual Meeting of the American Academy of Neurology
3. Elsevier Selected as New Publisher of The American Journal of Geriatric Psychiatry
4. Shire to Present Scientific Data Across Range of Psychiatric Disorders at American Psychiatric Association Annual Meeting May 5-9
5. Data Presented at the American Psychiatric Association Annual Meeting Supports Gender-Specific Dosing of Intermezzo® (zolpidem tartrate) Sublingual Tablets CIV
6. New Data to be Presented at the Annual American Thoracic Society International Conference Demonstrates Depth of Boehringer Ingelheim Respiratory Research Pipeline
7. NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
8. Pharmacyclics Announces Oral Presentations and Clinical Update of Ibrutinib (PCI-32765) at the 2012 Annual Meeting of the American Society of Clinical Oncology
9. Purdue Pharma L.P. To Present Analysis Of Butrans® (buprenorphine) Transdermal System CIII Clinical Data At American Pain Society Annual Meeting
10. Percutaneous Tibial Nerve Stimulation Included in the American Urological Associations Overactive Bladder Clinical Treatment Guidelines
11. Lilly Diabetes Presents Phase II Blood Pressure and Heart Rate Data on Investigational GLP-1 Analog Candidate, Dulaglutide, in Patients with Type 2 Diabetes at the 27th American Society of Hypertension Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2017)... , April 18, 2017  Cardinal Health (NYSE: ... fiscal 2017 earnings per share (EPS) guidance and ... This is in conjunction with this morning,s announcement of ... Thrombosis and Nutritional Insufficiency businesses. Cardinal Health ... operations will be at the bottom of its previous ...
(Date:4/18/2017)... DALLAS , April 18, 2017 Viverae ... proud to announce the integration of IBM ® ... platform to deliver targeted communications for a personalized experience. ... meaningful actions on their health in real time. The ... that matter most to members, wherever they are in ...
(Date:4/18/2017)... DIEGO , April 18, 2017  Astute Medical, ... a case series to be presented at the 2017 ... which begins today and continues through April 22. Physicians ... IGFBP-7 , used to assess risk for acute kidney ... decompensated heart failure (ADHF). Elevated levels ...
Breaking Medicine Technology:
(Date:4/26/2017)... ... April 26, 2017 , ... RawTrition now brings you BioEnergy which is ... from SUPERFOODS! , RawTrition is taking nutrients to the next level! ... body recognizes its raw form (unlike the synthetically made options that are on the ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... breakthrough topical cream that’s the first in a new class of photodynamic cosmetics ... overall appearance of skin, visibly reduce outward signs of aging, and minimize the ...
(Date:4/25/2017)... ... 2017 , ... As President Trump challenges the status quo ... administration could impact the employee benefits industry. James Slotnick, AVP, Government Relations, for ... make it through Congress. His discussion will focus on the current state of ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... targets, they rely on contracted partners to help with process innovation in drug ... combined drug formulation experience along with state-of-the-art analytical equipment in support of their ...
(Date:4/25/2017)... (PRWEB) , ... April 25, 2017 , ... ... addition of predictive analytics to its patient care management module. Using this new ... before a patient has been initiated on continuous positive airway pressure (CPAP), oral, ...
Breaking Medicine News(10 mins):